Moolec Science SA Ordinary Shares Market Cap ($617.20K)
Market Cap & Net Worth: Moolec Science SA Ordinary Shares (MLEC)
Moolec Science SA Ordinary Shares market cap. Moolec Science SA Ordinary Shares (NASDAQ:MLEC) has a market capitalization of $617.20K ($617.20K) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30954 globally and #6288 in its home market, demonstrating a -50.58% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Moolec Science SA Ordinary Shares's stock price $0.85 by its total outstanding shares 726118 (726.12K). Also see Moolec Science SA Ordinary Shares cash conversion from operations for how efficiently the company converts equity into cash flow.
Moolec Science SA Ordinary Shares Market Cap History (2021–2026)
Moolec Science SA Ordinary Shares market cap history from 2021 to 2026. Data shows change from $7.16 Million to $617.20K (-35.02% CAGR). Check latest Moolec Science SA Ordinary Shares stock price today for real-time trading data and today's change.
Index Memberships
Moolec Science SA Ordinary Shares is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$40.12 Trillion | 0.00% | #2866 of 3165 |
Weight: Moolec Science SA Ordinary Shares's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Moolec Science SA Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Moolec Science SA Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Moolec Science SA Ordinary Shares annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Moolec Science SA Ordinary Shares's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $1.79 Million | $905.05K | -$51.79 Million | 1.97x | N/A |
| 2024 | $586.85K | $5.63 Million | -$7.31 Million | 0.10x | N/A |
| 2025 | $184.87K | $333.61 Million | -$111.46 Million | 0.00x | N/A |
Competitor Companies of MLEC by Market Capitalization
Companies near Moolec Science SA Ordinary Shares in the global market cap rankings as of November 5, 2026. Also see MLEC total asset value for a full breakdown of the balance sheet.
Key companies related to Moolec Science SA Ordinary Shares by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #181 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #373 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #415 globally with a market cap of $67.74 Billion USD ( AU$95.74 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #503 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #181 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $549.04 |
| #373 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $930.67 |
| #415 | CSL Ltd | AU:CSL | $67.74 Billion | AU$197.34 |
| #503 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $258.38 |
Market Capitalization of Moolec Science SA Ordinary Shares (2021–2026)
Market capitalization of Moolec Science SA Ordinary Shares from 2021 to today. Between 2021 and today, Moolec Science SA Ordinary Shares's market cap moved from $7.16 Million to $ 617.20K, with a yearly change of -35.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $617.20K | +233.86% |
| 2025 | $184.87K | -68.50% |
| 2024 | $586.85K | -67.15% |
| 2023 | $1.79 Million | -79.67% |
| 2022 | $8.79 Million | +22.72% |
| 2021 | $7.16 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Moolec Science SA Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $617.20K USD |
| MoneyControl | $617.20K USD |
| MarketWatch | $617.20K USD |
| marketcap.company | $617.20K USD |
| Reuters | $617.20K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Moolec Science SA Ordinary Shares
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans… Read more